Outsourcing STREAM

  1. What Researchers Should Look For When Choosing A CLD Partner 11/7/2025

    A strong track record in compliant saline production and scalable quality is key when selecting a biomanufacturing partner. See how these factors help ensure regulatory alignment and long-term success.

  2. Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities 7/8/2022

    View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.

  3. Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion 3/2/2021

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally. With continuous growth in China’s population, we have seen an increase in demand for human therapeutics and vaccines and an even greater need for investment in public health and safety to develop biopharmaceutical products in China.

  4. Level Up With Product Characterization 3/12/2021

    In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and support, you can find a smoother, faster path to the finish line.

  5. Raman PAT Platform – Model Building Support Animation 11/16/2021

    Interested in implementing Raman as a PAT tool to monitor your bioprocesses in-line and in real time? But not a chemometric expert? Our experts are here to support you! Watch this video to learn more.

  6. Commercial Readiness with Orca Bio's Dan Kirby 9/14/2023

    Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.

  7. Combining Expertise With Best-In-Class Technology 10/20/2021

    Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner to pioneer the path to cures.

  8. Increasing The Reach Of Cell And Gene Therapies 4/29/2021

    The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized if the industry approaches manufacturing parity with monoclonal antibodies. A mixture of innovation and brute-force streamlining is needed to create viable cell and gene therapy templates. In this video, we discuss how upstream process optimization is ripe for innovative approaches.

  9. Discovering A Unique Multimillion Euro Nanotechnology Facility 10/25/2024

    Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.

  10. Explore The M Lab Collaboration Center In Burlington MA 9/19/2022

    Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.